Literature DB >> 16684602

Different early pathogenesis in myotilinopathy compared to primary desminopathy.

Dirk Fischer1, Christoph S Clemen, Montse Olivé, Isidro Ferrer, Bertrand Goudeau, Udo Roth, Petra Badorf, Mike P Wattjes, Götz Lutterbey, Thomas Kral, Peter F M van der Ven, Dieter O Fürst, Patrick Vicart, Lev G Goldfarb, Monica Moza, Olli Carpen, Julia Reichelt, Rolf Schröder.   

Abstract

Mutations in the human myotilin gene may cause limb-girdle muscular dystrophy 1A and myofibrillar myopathy. Here, we describe a German patient with the clinically distinct disease phenotype of late adult onset distal anterior leg myopathy caused by a heterozygous S55F myotilin mutation. In addition to a thorough morphological and clinical analysis, we performed for the first time a protein chemical analysis and transient transfections. Morphological analysis revealed an inclusion body myopathy with myotilin- and desmin-positive aggregates. The clinical and pathological phenotype considerably overlaps with late onset distal anterior leg myopathy of the Markesbery-Griggs type. Interestingly, all three analyzed myotilin missense mutations (S55F, S60F and S60C) do not lead to gross changes in the total amount of myotilin or to aberrant posttranslational modifications in diseased muscle, as observed in a number of muscular dystrophies. Transiently transfected wild-type and S55F mutant myotilin similarly colocalised with actin-containing stress fibers in BHK-21 cells. Like the wild-type protein, mutated myotilin did not disrupt the endogenous desmin cytoskeleton or lead to pathological protein aggregation in these cells. This lack of an obvious dominant negative effect sharply contrasts to transfections with, for instance, the disease-causing A357P desmin mutant. In conclusion our data indicate that the disorganization of the extrasarcomeric cytoskeleton and the presence of desmin-positive aggregates are in fact late secondary events in the pathogenesis of primary myotilinopathies, rather than directly related. These findings suggest that unrelated molecular pathways may result in seemingly similar disease phenotypes at late disease stages.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684602     DOI: 10.1016/j.nmd.2006.03.007

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  9 in total

Review 1.  Molecular insights into cardiomyopathies associated with desmin (DES) mutations.

Authors:  Andreas Brodehl; Anna Gaertner-Rommel; Hendrik Milting
Journal:  Biophys Rev       Date:  2018-06-20

2.  Target genes of neuron-restrictive silencer factor are abnormally up-regulated in human myotilinopathy.

Authors:  Marta Barrachina; Jesús Moreno; Salvador Juvés; Dolores Moreno; Montse Olivé; Isidre Ferrer
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

3.  Intermediate filament diseases: desminopathy.

Authors:  Lev G Goldfarb; Montse Olivé; Patrick Vicart; Hans H Goebel
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

4.  Distinct muscle imaging patterns in myofibrillar myopathies.

Authors:  D Fischer; R A Kley; K Strach; C Meyer; T Sommer; K Eger; A Rolfs; W Meyer; A Pou; J Pradas; C M Heyer; A Grossmann; A Huebner; W Kress; J Reimann; R Schröder; B Eymard; M Fardeau; B Udd; L Goldfarb; M Vorgerd; M Olivé
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

5.  Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy.

Authors:  Vivek S Peche; Tad A Holak; Bhagyashri D Burgute; Kosmas Kosmas; Sushant P Kale; F Thomas Wunderlich; Fatiha Elhamine; Robert Stehle; Gabriele Pfitzer; Klaus Nohroudi; Klaus Addicks; Florian Stöckigt; Jan W Schrickel; Julia Gallinger; Michael Schleicher; Angelika A Noegel
Journal:  Cell Mol Life Sci       Date:  2012-09-04       Impact factor: 9.261

6.  Generalized muscle pseudo-hypertrophy and stiffness associated with the myotilin Ser55Phe mutation: a novel myotilinopathy phenotype?

Authors:  Josep Gamez; Judith Armstrong; Alexey Shatunov; Albert Selva-O'Callaghan; Rosa Dominguez-Oronoz; Arantxa Ortega; Lev Goldfarb; Isidre Ferrer; Montse Olivé
Journal:  J Neurol Sci       Date:  2008-11-22       Impact factor: 3.181

7.  Panorama of the distal myopathies.

Authors:  Marco Savarese; Jaakko Sarparanta; Anna Vihola; Per Harald Jonson; Mridul Johari; Salla Rusanen; Peter Hackman; Bjarne Udd
Journal:  Acta Myol       Date:  2020-12-01

8.  Exome sequencing identifies titin mutations causing hereditary myopathy with early respiratory failure (HMERF) in families of diverse ethnic origins.

Authors:  Camilo Toro; Montse Olivé; Marinos C Dalakas; Kumaraswami Sivakumar; Juan M Bilbao; Felix Tyndel; Noemí Vidal; Eva Farrero; Nyamkhishig Sambuughin; Lev G Goldfarb
Journal:  BMC Neurol       Date:  2013-03-20       Impact factor: 2.474

9.  New insights into the protein aggregation pathology in myotilinopathy by combined proteomic and immunolocalization analyses.

Authors:  A Maerkens; M Olivé; A Schreiner; S Feldkirchner; J Schessl; J Uszkoreit; K Barkovits; A K Güttsches; V Theis; M Eisenacher; M Tegenthoff; L G Goldfarb; R Schröder; B Schoser; P F M van der Ven; D O Fürst; M Vorgerd; K Marcus; R A Kley
Journal:  Acta Neuropathol Commun       Date:  2016-02-03       Impact factor: 7.801

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.